Table I.

Patient demographics with treatment characteristics and results

Participant	Age, sex	Fitzpatrick skin type	Laser type (no. of sessions)	CO₂ laser parameters	TXA treatment (duration)	Initial mMASI score	Posttreatment mMASI score	Complications
1	54 y, F	III	CO₂† (2)	24 mJ, 50/cm	No	2.15∗	0.5∗	Swelling
			CO₂†	22 mJ, 75/cm	No	0.75	0.6	No
2	51 y, F	III	CO₂† (3)	22 mJ, 75/cm	Yes (7 wk)	6.7∗	3.55∗	No
			CO₂† then laser toning‡ (1)	24 mJ, 75/cm	Yes (11 wk)	3.7	2.75	No
			CO₂†	24 mJ, 75/cm	Yes (16 wk)	3.05	1.95	No
3	59 y, F	IV	CO₂† (1)	22 mJ, 100/cm	Yes (2.4 wk)	6.45	5.25	No
4	66 y, F	III	CO₂† (1) then laser toning‡ (1)	28 mJ, 50/cm	Yes (2 wk)	2.7	2.1	No
5	53 y, F	III	CO₂† (1) then laser toning‡ (1)	24 mJ, 100/cm	Yes (1 wk)	0.9	1.8	No
6	35 y, F	III	CO₂† (1) then laser toning‡ (1)	22 mJ, 75/cm	Yes (4.9 wk)	0.75∗	1.95∗	Hyperpigmentation
7	47 y, F	III	CO₂† (1) then laser toning‡ (1)	26 mJ, 50/cm	Yes (4 wk)	2.1	0.75	No
8	61 y, F	IV	CO₂† (1)	50 mJ, 50/cm	No	1.65∗	0.6∗	No
9	65 y, F	IV	CO₂† (1) then laser toning‡ (1)	26 mJ, 50/cm	Yes (16 wk)	7.2	5.55	No
10	57 y, F	III	CO₂† (1)	24 mJ, 75/cm	No	3.45	2.25	No
11	61 y, F	III	CO₂† (1) then laser toning‡ (1)	24 mJ, 100/cm	No	3.75	4.2	No
12	48 y, F	III	CO₂† (2) then laser toning‡ (1)	24 mJ, 75/cm	No	0.6	0.75	No
			CO₂†	30 mJ, 50/cm	No	1.05∗	0.3∗	No

^∗P < .05.

^†Lutronic eCO₂.

^‡Lutronic PicoPlus/Spectra.